Immuron (IMRN) EBITDA Margin (2016 - 2024)
Immuron (IMRN) recorded quarterly EBITDA Margin of 63.56% in Q4 2024, down 172.37% quarter-over-quarter from 87.82% in Q4 2023, and down 15138.0% on a YoY basis from N/an in Q1 2024.
Immuron (IMRN) EBITDA Margin (2016 - 2024) Analysis & Trends
Immuron's EBITDA Margin history runs 9 years deep, the most recent figure standing at 63.56% for Q4 2024.
- In Q4 2024, EBITDA Margin fell 15138.0% year-over-year to 63.56%; the TTM figure through Dec 2024 stood at 63.56% (down 15599.0% YoY), while the FY2025 annual figure was 72.66%, up 4472.0% from the prior year.
- EBITDA Margin was 63.56% for Q4 2024 at Immuron, down from 87.82% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 339.11% in Q4 2022 to a low of 387605372.77% in Q4 2020.
- Historically, EBITDA Margin has averaged 64601214.72% across 5 years, with a median of 423.83% in 2021.
- The sharpest annual moves came in 2020 and 2021: EBITDA Margin sank 2000000000 bps in 2020, then jumped 2000000000 bps in 2021.
- A 5-year view of EBITDA Margin shows it stood at 387605372.77% in 2020, then surged by 100 bps to 784.1% in 2021, then surged by 143 bps to 339.11% in 2022, then plunged by 74 bps to 87.82% in 2023, then slumped by 172 bps to 63.56% in 2024.
- The last three EBITDA Margin figures came in at 63.56% (Q4 2024), 87.82% (Q4 2023), and 1494.83% (Q2 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -6.43% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 38.10% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Immuron | 921.61 Mn | 921.58 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -63.56% |
| Dec 31, 2023 | 87.82% |
| Jun 30, 2023 | -1,494.83% |
| Dec 31, 2022 | 339.11% |
| Dec 31, 2021 | -784.10% |
| Dec 31, 2020 | -387,605,372.77% |
| Dec 31, 2019 | -99.26% |
| Dec 31, 2018 | 173.19% |
| Dec 31, 2017 | -202.76% |
| Dec 31, 2016 | -490.79% |
| Jun 30, 2016 | -379.89% |